Global Pet NSAIDs Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Pet NSAIDs Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Pet NSAIDs industry at home and abroad, estimate the overall market scale of the Pet NSAIDs industry and the market share of major countries, Pet NSAIDs industry, and study and judge the downstream market demand of Pet NSAIDs through systematic research, Analyze the competition pattern of Pet NSAIDs, so as to help solve the pain points of various stakeholders in Pet NSAIDs industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Pet NSAIDs Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Pet NSAIDs Market?
Zoetis
Elanco
PREVICOX
Metacam
Chanelle Pharma
AVENTIX
Woodruff
KRKA UK Ltd
Dechra
Parnell
VetUK
Norbrook
Alivira Animal Health
Vedco Inc
Vethical
Vetoquinol
Pivetal
Major Type of Pet NSAIDs Covered in XYZResearch report
Carprofen
Deracoxib
Firocoxib
Meloxicam
Application Segments Covered in XYZResearch Market
Dog
Cat
Horse
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Pet NSAIDs Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pet NSAIDs Market by Value
2.2.1 Global Pet NSAIDs Revenue by Type
2.2.2 Global Pet NSAIDs Market by Value (%)
2.3 Global Pet NSAIDs Market by Production
2.3.1 Global Pet NSAIDs Production by Type
2.3.2 Global Pet NSAIDs Market by Production (%)
3. The Major Driver of Pet NSAIDs Industry
3.1 Historical & Forecast Global Pet NSAIDs Demand
3.2 Largest Application for Pet NSAIDs (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Pet NSAIDs Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Pet NSAIDs Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Pet NSAIDs Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Pet NSAIDs Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Pet NSAIDs Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Pet NSAIDs Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Pet NSAIDs Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Pet NSAIDs Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Pet NSAIDs Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Pet NSAIDs Average Price Trend
12.1 Market Price for Each Type of Pet NSAIDs in US (2018-2022)
12.2 Market Price for Each Type of Pet NSAIDs in Europe (2018-2022)
12.3 Market Price for Each Type of Pet NSAIDs in China (2018-2022)
12.4 Market Price for Each Type of Pet NSAIDs in Japan (2018-2022)
12.5 Market Price for Each Type of Pet NSAIDs in India (2018-2022)
12.6 Market Price for Each Type of Pet NSAIDs in Korea (2018-2022)
12.7 Market Price for Each Type of Pet NSAIDs in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Pet NSAIDs Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Pet NSAIDs
14. Pet NSAIDs Competitive Landscape
14.1 Zoetis
14.1.1 Zoetis Company Profiles
14.1.2 Zoetis Product Introduction
14.1.3 Zoetis Pet NSAIDs Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Elanco
14.2.1 Elanco Company Profiles
14.2.2 Elanco Product Introduction
14.2.3 Elanco Pet NSAIDs Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 PREVICOX
14.3.1 PREVICOX Company Profiles
14.3.2 PREVICOX Product Introduction
14.3.3 PREVICOX Pet NSAIDs Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Metacam
14.4.1 Metacam Company Profiles
14.4.2 Metacam Product Introduction
14.4.3 Metacam Pet NSAIDs Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Chanelle Pharma
14.5.1 Chanelle Pharma Company Profiles
14.5.2 Chanelle Pharma Product Introduction
14.5.3 Chanelle Pharma Pet NSAIDs Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 AVENTIX
14.6.1 AVENTIX Company Profiles
14.6.2 AVENTIX Product Introduction
14.6.3 AVENTIX Pet NSAIDs Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Woodruff
14.7.1 Woodruff Company Profiles
14.7.2 Woodruff Product Introduction
14.7.3 Woodruff Pet NSAIDs Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 KRKA UK Ltd
14.8.1 KRKA UK Ltd Company Profiles
14.8.2 KRKA UK Ltd Product Introduction
14.8.3 KRKA UK Ltd Pet NSAIDs Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Dechra
14.9.1 Dechra Company Profiles
14.9.2 Dechra Product Introduction
14.9.3 Dechra Pet NSAIDs Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Parnell
14.10.1 Parnell Company Profiles
14.10.2 Parnell Product Introduction
14.10.3 Parnell Pet NSAIDs Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 VetUK
14.12 Norbrook
14.13 Alivira Animal Health
14.14 Vedco Inc
14.15 Vethical
14.16 Vetoquinol
14.17 Pivetal
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Pet NSAIDs Industry (Volume)
Figure 2. Pet NSAIDs Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Pet NSAIDs Revenue in 2022
Figure 5. US Pet NSAIDs Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pet NSAIDs Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pet NSAIDs Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pet NSAIDs Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pet NSAIDs Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pet NSAIDs Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pet NSAIDs Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pet NSAIDs Revenue, by Type (Million USD) (2018-2028)
Table 4. Pet NSAIDs Production, by Type (K Unit) (2018-2028)
Table 5. Pet NSAIDs Demand (K Unit) by Application (2018-2028)
Table 6. Pet NSAIDs Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Pet NSAIDs Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pet NSAIDs Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pet NSAIDs in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Pet NSAIDs in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Pet NSAIDs in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Pet NSAIDs in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Pet NSAIDs in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Pet NSAIDs in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Pet NSAIDs in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Zoetis Profiles
Table 61. Zoetis Pet NSAIDs Product Introduction
Table 62. Zoetis Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Zoetis Strategic initiatives
Table 64. Elanco Profiles
Table 65. Elanco Pet NSAIDs Product Introduction
Table 66. Elanco Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Elanco Strategic initiatives
Table 68. PREVICOX Profiles
Table 69. PREVICOX Pet NSAIDs Product Introduction
Table 70. PREVICOX Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. PREVICOX Strategic initiatives
Table 72. Metacam Profiles
Table 73. Metacam Pet NSAIDs Product Introduction
Table 74. Metacam Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Metacam Strategic initiatives
Table 76. Chanelle Pharma Profiles
Table 77. Chanelle Pharma Pet NSAIDs Product Introduction
Table 78. Chanelle Pharma Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Chanelle Pharma Strategic initiatives
Table 80. AVENTIX Profiles
Table 81. AVENTIX Pet NSAIDs Product Introduction
Table 82. AVENTIX Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. AVENTIX Strategic initiatives
Table 84. Woodruff Profiles
Table 85. Woodruff Pet NSAIDs Product Introduction
Table 86. Woodruff Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Woodruff Strategic initiatives
Table 88. KRKA UK Ltd Profiles
Table 89. KRKA UK Ltd Pet NSAIDs Product Introduction
Table 90. KRKA UK Ltd Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. KRKA UK Ltd Strategic initiatives
Table 92. Dechra Profiles
Table 93. Dechra Pet NSAIDs Product Introduction
Table 94. Dechra Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Dechra Strategic initiatives
Table 97. Parnell Profiles
Table 98. Parnell Pet NSAIDs Product Introduction
Table 99. Parnell Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Parnell Strategic initiatives
Table 101. VetUK Profiles
Table 102. VetUK Pet NSAIDs Product Introduction
Table 103. VetUK Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. VetUK Strategic initiatives
Table 105. Norbrook Profiles
Table 106. Norbrook Pet NSAIDs Product Introduction
Table 107. Norbrook Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Norbrook Strategic initiatives
Table 109. Alivira Animal Health Profiles
Table 110. Alivira Animal Health Pet NSAIDs Product Introduction
Table 111. Alivira Animal Health Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Alivira Animal Health Strategic initiatives
Table 113. Vedco Inc Profiles
Table 114. Vedco Inc Pet NSAIDs Product Introduction
Table 115. Vedco Inc Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Vedco Inc Strategic initiatives
Table 117. Vethical Profiles
Table 118. Vethical Pet NSAIDs Product Introduction
Table 119. Vethical Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Vethical Strategic initiatives
Table 121. Vetoquinol Profiles
Table 122. Vetoquinol Pet NSAIDs Product Introduction
Table 123. Vetoquinol Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Vetoquinol Strategic initiatives
Table 125. Pivetal Profiles
Table 126. Pivetal Pet NSAIDs Product Introduction
Table 127. Pivetal Pet NSAIDs Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Pivetal Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices